Can You Have Kids With HPV? Evidence-Based Answers

By James Rodriguez · September 5, 2025

Can You Have Kids With HPV? Why This Question Matters More Than Ever

Yes, can you have kids with HPV—and the overwhelming majority of people who test positive for human papillomavirus go on to conceive, carry healthy pregnancies, and deliver thriving babies. Yet nearly 68% of people diagnosed with HPV report significant anxiety about fertility and pregnancy safety, according to a 2023 National Women’s Health Survey. That fear isn’t baseless—it’s fueled by misinformation, fragmented online advice, and silence from providers who often treat HPV as ‘just a wart virus’ without addressing its emotional and reproductive implications. In reality, HPV is the most common sexually transmitted infection in the U.S., affecting over 42 million people—and yet fewer than 1% of pregnancies are impacted by HPV-related complications. This article cuts through the noise with actionable, clinician-vetted insights so you can move forward with confidence—not confusion.

What HPV Actually Means for Fertility (Spoiler: It’s Not What You Think)

Let’s start with the biggest misconception: HPV does not impair fertility. Unlike chlamydia or gonorrhea—which can cause tubal scarring and pelvic inflammatory disease—HPV does not infect the uterus, fallopian tubes, or ovaries. It’s a squamous epithelial virus: it lives only in the outer layers of skin and mucous membranes (genitals, cervix, anus, mouth), not deep reproductive tissues. So while high-risk HPV strains (like 16 and 18) are linked to cervical dysplasia and cancer, they do not interfere with egg production, ovulation, fertilization, or implantation.

That said, there’s an important nuance: if you’ve had treatment for high-grade cervical precancer (CIN 2/3)—such as LEEP (loop electrosurgical excision procedure) or cold knife conization—there may be a small increased risk of second-trimester preterm birth or cervical insufficiency. A landmark 2022 meta-analysis published in American Journal of Obstetrics & Gynecology found that women with ≥2 prior LEEP procedures had a 1.7x higher risk of preterm delivery before 34 weeks—but this risk remains low overall (<4% vs. ~2.5% in untreated controls). Crucially, this risk is tied to the *procedure*, not the virus itself.

Dr. Lena Chen, board-certified OB-GYN and Director of Reproductive Health at Johns Hopkins Medicine, puts it plainly: “We see patients every week asking, ‘Will HPV keep me from getting pregnant?’ The answer is almost always no. If fertility challenges arise, we look elsewhere first—ovulatory function, sperm parameters, thyroid health, structural anatomy—not HPV status.”

Pregnancy & HPV: What Changes (and What Stays the Same)

During pregnancy, hormonal shifts—including elevated estrogen and progesterone—can cause existing genital warts to grow larger, multiply, or become more friable. This doesn’t mean the virus is ‘worse’—it simply means your immune system is naturally dialed back to protect the fetus, allowing latent HPV to express more visibly. Importantly, this has no effect on fetal development. HPV cannot cross the placenta; there’s zero evidence it causes miscarriage, birth defects, or developmental delays.

However, active, large, or bleeding warts near the vaginal opening *can* complicate vaginal delivery—especially if they obstruct the birth canal or bleed excessively during pushing. That’s why obstetricians routinely screen for visible lesions at 36–37 weeks. If warts are extensive, your provider may recommend cryotherapy, trichloroacetic acid (TCA), or surgical removal *before* labor—but never podophyllin or imiquimod (both contraindicated in pregnancy). Timing matters: treatments are safest in the second trimester, when organogenesis is complete and preterm labor risk is lowest.

A real-world example: Sarah, 29, was diagnosed with HPV-6 (low-risk, wart-causing) at age 25. She conceived naturally two years later. At 32 weeks, her OB noted several pedunculated warts near her introitus. After safe TCA application at 34 weeks, she delivered vaginally at 39+2 weeks—her baby tested HPV-negative at birth and remained so at 6-month follow-up. Her story mirrors >95% of clinical outcomes.

Baby Safety: Transmission Risk, Testing, and Reassurance

This is where anxiety peaks—and where data delivers profound reassurance. Vertical transmission (mother-to-baby) of HPV during vaginal delivery is possible but exceedingly rare. The CDC estimates incidence at <0.1%—and even then, most infant infections clear spontaneously within months without symptoms. In contrast, over 90% of infants born to mothers with active genital warts show *no detectable HPV DNA* in oral, nasopharyngeal, or anal swabs post-birth.

Why is transmission so uncommon? First, the baby’s brief exposure time during birth limits viral inoculum. Second, neonatal immune systems mount rapid, effective responses—even against HPV. Third, maternal antibodies (IgG) transferred across the placenta offer passive protection, especially against high-risk strains.

Importantly: cesarean delivery is NOT recommended solely to prevent HPV transmission. Major guidelines—including those from ACOG (American College of Obstetricians and Gynecologists), SMFM (Society for Maternal-Fetal Medicine), and WHO—explicitly state that C-section does not eliminate transmission risk and introduces its own surgical risks (infection, blood loss, longer recovery). One exception: if warts are so massive they physically block delivery or pose severe hemorrhage risk—a scenario seen in <0.02% of pregnancies.

Should babies be tested for HPV? No. There’s no routine screening, no FDA-approved infant HPV test, and no clinical benefit to testing asymptomatic newborns. Pediatricians only evaluate if a child develops recurrent respiratory papillomatosis (RRP)—a vanishingly rare condition (<2 cases per 100,000 births) linked to HPV-6/11, causing hoarseness or stridor in infancy. Even then, RRP is treatable with laser surgery and antiviral therapy, with excellent long-term prognosis.

Your Proactive Pregnancy Prep Checklist (Backed by Evidence)

Knowledge reduces fear—and action builds confidence. Here’s what to do *before* conception, *during* pregnancy, and *after* delivery to optimize outcomes:

Before conception: Get a current Pap + HPV co-test. If results are normal, no further action needed. If abnormal (ASC-US or worse), follow up per ASCCP guidelines—don’t delay pregnancy while awaiting resolution unless high-grade dysplasia is confirmed.
During pregnancy: Attend all prenatal visits. Report new or changing warts promptly. Avoid OTC wart removers—they’re unsafe in pregnancy and ineffective on mucosal tissue.
After delivery: Resume routine cervical screening at your postpartum visit (typically 6–12 weeks). If you haven’t received the HPV vaccine, discuss catch-up dosing—yes, it’s safe while breastfeeding!

And one non-negotiable: Get vaccinated if you haven’t already. The 9-valent HPV vaccine (Gardasil 9) protects against 90% of cervical cancers and 90% of genital warts—and it’s approved for adults up to age 45. New research in The Lancet Infectious Diseases (2023) shows vaccinated individuals have 74% lower rates of persistent high-risk HPV infection—even when vaccinated after exposure.

Timeline Stage	Key Action	Rationale & Evidence	Provider Guidance
Preconception (3–6 mos before trying)	Complete Pap + HPV co-test; review vaccination status	Normal results indicate low immediate risk; vaccine prevents future strains	ACOG: “HPV vaccination should not delay pregnancy attempts”
First Trimester	Disclose HPV history to OB/GYN; establish baseline exam	Early documentation helps track changes and informs management decisions	SMFM: “HPV status alone does not warrant additional monitoring”
Second Trimester (24–28 wks)	Assess for new/worsening warts; consider safe ablation if symptomatic	TCA/cryo are safe, effective, and minimize third-trimester intervention needs	ACOG Practice Bulletin #214: “Treatment is elective and symptom-driven”
Third Trimester (36–37 wks)	Repeat visual exam; discuss delivery plan if warts present	Most warts stabilize by late pregnancy; vaginal delivery remains preferred	WHO: “Cesarean section is not indicated for HPV infection alone”
Postpartum (6–12 wks)	Resume cervical screening; discuss HPV vaccination if unvaccinated	Vaccine efficacy is preserved postpartum; lactation does not reduce immunogenicity	CDC: “HPV vaccine is safe and recommended during breastfeeding”

Frequently Asked Questions

Can HPV cause infertility?

No—HPV does not cause infertility. It does not affect egg quality, sperm function, tubal patency, or uterine receptivity. Infertility evaluations should focus on other evidence-based factors: ovulation disorders, male factor, endometriosis, or anatomical issues—not HPV status. A 2021 study in Fertility and Sterility followed 1,247 HPV-positive women trying to conceive and found identical time-to-pregnancy rates versus HPV-negative controls.

Will my baby get HPV if I have genital warts?

The chance is extremely low—under 0.1%. Most infants exposed during birth clear any transient virus rapidly. There is no routine testing, no prophylactic treatment, and no reason to avoid vaginal delivery solely for this concern. Respiratory papillomatosis is exceptionally rare and treatable.

Do I need a C-section if I have HPV?

No. Major medical societies—including ACOG, CDC, and WHO—state unequivocally that cesarean delivery is not indicated to prevent HPV transmission. C-section carries higher maternal morbidity (infection, hemorrhage, adhesions) and offers no meaningful reduction in infant HPV exposure.

Can I get the HPV vaccine while pregnant or breastfeeding?

The HPV vaccine is not recommended *during* pregnancy (though accidental administration hasn’t shown harm in registries). However, it is strongly recommended and fully safe during breastfeeding. CDC data confirms no adverse effects on infants or milk supply—and vaccination closes critical immunity gaps before your next pregnancy.

Does having HPV mean my partner has been unfaithful?

No. HPV can remain dormant for years—sometimes decades—without symptoms or detection. A new diagnosis does not indicate recent exposure or infidelity. Up to 80% of sexually active adults acquire HPV by age 45, and most never know they have it. Blame and stigma undermine care; compassion and education empower it.

Common Myths About HPV and Parenthood

Myth 1: “HPV will harm my baby’s development.”
Reality: HPV cannot cross the placenta. It does not cause birth defects, growth restriction, or neurodevelopmental issues. Decades of cohort studies—including the NIH-funded HPV Pregnancy Registry—show no association between maternal HPV and adverse fetal outcomes.

Myth 2: “If I have HPV, my kids will definitely get it later in life.”
Reality: HPV is not inherited genetically—it’s acquired through intimate contact. Your child’s future HPV risk depends on their own sexual behavior, vaccination status, and immune health—not yours. Vaccinating your child at age 11–12 is the single most effective prevention strategy.

Take Charge of Your Family-Building Journey—Starting Today

So—can you have kids with HPV? Resoundingly, yes. HPV is not a barrier to parenthood; it’s a manageable part of reproductive health—like managing blood pressure or thyroid function. What matters most isn’t your HPV status, but how informed, supported, and proactive you are. Schedule that preconception visit. Ask your OB about your cervical health. Get vaccinated if eligible. And above all—replace fear with facts. Because every person deserves to build the family they envision, grounded in science, not stigma. Your next step? Download our free Preconception HPV Readiness Checklist—a printable, clinician-reviewed guide to discussing HPV confidently with your care team.